Sonkin D, Thomas A, Teicher BA. Cancer treatments: past, present, and future. Cancer Genet. 2024;286:18–24. https://doi.org/10.1016/j.cancergen.2024.06.002.
Article CAS PubMed Google Scholar
Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557–88. https://doi.org/10.1038/s41575-020-0310-z.
Article PubMed PubMed Central Google Scholar
Clements O, Eliahoo J, Kim JU, Taylor-Robinson SD, Khan SA. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis. J Hepatol. 2020;72(1):95–103. https://doi.org/10.1016/j.jhep.2019.09.007.
Zhao H, Lu B. Prediction of multiple serum tumor markers in hepatolithiasis complicated with intrahepatic cholangiocarcinoma. Cancer Manag Res. 2022;14:249–55. https://doi.org/10.2147/CMAR.S344711.
Article PubMed PubMed Central Google Scholar
Brindley PJ, Bachini M, Ilyas SI, et al. Cholangiocarcinoma. Nat Rev Dis Primers. 2021;7(1):65. https://doi.org/10.1038/s41572-021-00300-2.
Article PubMed PubMed Central Google Scholar
Ilyas SI, Gores GJ. Emerging molecular therapeutic targets for cholangiocarcinoma. J Hepatol. 2017;67(3):632–44. https://doi.org/10.1016/j.jhep.2017.03.026.
Article CAS PubMed PubMed Central Google Scholar
Qu S, Liu Z, Yang X, et al. The emerging functions and roles of circular RNAs in cancer. Cancer Lett. 2018;414:301–9. https://doi.org/10.1016/j.canlet.2017.11.022.
Article CAS PubMed Google Scholar
Szabo L, Salzman J. Detecting circular RNAs: bioinformatic and experimental challenges. Nat Rev Genet. 2016;17(11):679–92. https://doi.org/10.1038/nrg.2016.114.
Article CAS PubMed PubMed Central Google Scholar
Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21(8):475–90. https://doi.org/10.1038/s41580-020-0243-y.
Article CAS PubMed Google Scholar
Wang M, Yu F, Wu W, et al. Circular RNAs: a novel type of non-coding RNA and their potential implications in antiviral immunity. Int J Biol Sci. 2017;13(12):1497–506. https://doi.org/10.7150/ijbs.22531.
Article CAS PubMed PubMed Central Google Scholar
Louis C, Desoteux M, Coulouarn C. Exosomal circRNAs: new players in the field of cholangiocarcinoma. Clin Sci (Lond). 2019;133(21):2239–44. https://doi.org/10.1042/CS20190940.
Article CAS PubMed Google Scholar
Han B, Chao J, Yao H. Circular RNA and its mechanisms in disease: from the bench to the clinic. Pharmacol Ther. 2018;187:31–44. https://doi.org/10.1016/j.pharmthera.2018.01.010.
Article CAS PubMed Google Scholar
Zhang X, Wang S, Wang H, et al. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway. Mol Cancer. 2019;18:20. https://doi.org/10.1186/s12943-018-0935-5.
Article PubMed PubMed Central Google Scholar
Yang H, Zhang H, Yang Y, et al. Hypoxia induced exosomal circRNA promotes metastasis of colorectal cancer via targeting GEF-H1/RhoA axis. Theranostics. 2020;10(18):8211–26. https://doi.org/10.7150/thno.44419.
Article CAS PubMed PubMed Central Google Scholar
Xu J, Ji L, Liang Y, et al. CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1. Signal Transduct Target Ther. 2020;5:298. https://doi.org/10.1038/s41392-020-00375-5.
Article CAS PubMed PubMed Central Google Scholar
Zhou P, Xie W, Huang HL, et al. CircRNA_100859 functions as an oncogene in colon cancer by sponging the miR-217-HIF-1α pathway. Aging (Albany NY). 2020;12(13):13338–53. https://doi.org/10.18632/aging.103438.
Article CAS PubMed Google Scholar
Wong CH, Lou UK, Fung FKC, et al. Circrtn4 promotes pancreatic cancer progression through a novel circrna-miRNA-lncrna pathway and stabilizing epithelial-mesenchymal transition protein. Mol Cancer. 2022;21:10. https://doi.org/10.1186/s12943-021-01481-w.
Article CAS PubMed PubMed Central Google Scholar
Chen Q, Wang H, Li Z, et al. Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription. J Hepatol. 2022;76(1):135–47. https://doi.org/10.1016/j.jhep.2021.08.027.
Article CAS PubMed Google Scholar
Liu H, Dilger PJ. Different strategies for cancer treatment: Targeting cancer cells or their neighbors? Chin J Cancer Res. 2025;37(2):289–92. https://doi.org/10.21147/j.issn.1000-9604.2025.02.12.
Article PubMed PubMed Central Google Scholar
Li H, Lan T, Liu H, et al. IL-6–induced cGGNBP2 encodes a protein to promote cell growth and metastasis in intrahepatic cholangiocarcinoma. Hepatology. 2022;75(6):1402–19. https://doi.org/10.1002/hep.32232.
Article CAS PubMed Google Scholar
Xu Y, Leng K, Yao Y, et al. A circular RNA, cholangiocarcinoma-associated circular RNA 1, contributes to cholangiocarcinoma progression, induces angiogenesis, and disrupts vascular endothelial barriers. Hepatology. 2021;73(4):1419–35. https://doi.org/10.1002/hep.31493.
Article CAS PubMed Google Scholar
Chen S, Chen Z, Li Z, et al. Tumor-associated macrophages promote cholangiocarcinoma progression via exosomal Circ_0020256. Cell Death Dis. 2022;13(1):94. https://doi.org/10.1038/s41419-022-04534-0.
Article CAS PubMed PubMed Central Google Scholar
Guan C, Liu L, Zhao Y, et al. YY1 and eIF4A3 are mediators of the cell proliferation, migration and invasion in cholangiocarcinoma promoted by circ-ZNF609 by targeting miR-432-5p to regulate LRRC1. Aging (Albany NY). 2021;13(23):25195–212. https://doi.org/10.18632/aging.203735.
Article CAS PubMed Google Scholar
Li D, Tang Z, Gao Z, Shen P, Liu Z, Dang X. Circular RNA CDR1as exerts oncogenic properties partially through regulating microRNA 641 in cholangiocarcinoma. Mol Cell Biol. 2020;40(15):e00042-e120. https://doi.org/10.1128/MCB.00042-20.
Article CAS PubMed PubMed Central Google Scholar
Xu Y, Gao P, Wang Z, et al. Circ-LAMP1 contributes to the growth and metastasis of cholangiocarcinoma via miR-556-5p and miR-567 mediated YY1 activation. J Cell Mol Med. 2021;25(7):3226–38. https://doi.org/10.1111/jcmm.16392.
Article CAS PubMed PubMed Central Google Scholar
Xu Y, Yao Y, Liu Y, et al. Elevation of circular RNA circ_0005230 facilitates cell growth and metastasis via sponging miR-1238 and miR-1299 in cholangiocarcinoma. Aging (Albany NY). 2019;11(7):1907–17. https://doi.org/10.18632/aging.101872.
Article CAS PubMed Google Scholar
Su Y, Yu T, Wang Y, Huang X, Wei X. Circular RNA circDNM3OS functions as a miR-145-5p sponge to accelerate cholangiocarcinoma growth and glutamine metabolism by upregulating MORC2. Onco Targets Ther. 2021;14:1117–29. https://doi.org/10.2147/OTT.S289241.
Comments (0)